Concepedia

Sylvia Zapf

SZ

5

Publications

159

Citations

5

H-Index

1995

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Lund University

Institute of Organic Chemistry

Sylvia Zapf is an author at Boehringer Ingelheim (Germany) specializing in medicine, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

1995–1997

5

Publications

5

Darlucins A and B, New Isocyanide Antibiotics from Sphaerellopsis filum(Darluca filum).

Sylvia Zapf, MARTIN HOßFELD, Heidrun Anke et al. · The Journal of Antibiotics · 1995 · 78 citations · Full text

Incrustoporin, a New Antibiotic from Incrustoporia carneola (Bres.) Ryv. (Basidiomycetes).

Sylvia Zapf, Timm Anke, Olov Sterner et al. · Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry · 1995 · 37 citations · Full text

, , +4

Favolon, a New Antifungal Triterpenoid from a Favolaschia Species.

Timm Anke, Andreas Werle, Sylvia Zapf et al. · The Journal of Antibiotics · 1995 · 22 citations · Full text

(+)-10α-Hydroxy-4-muurolen-3-one, a New Inhibitor of Leukotriene Biosynthesis from a Favolaschia Species. Comparison with Other Sesquiterpenes

Sylvia Zapf, Annette Wunder, Timm Anke et al. · Zeitschrift für Naturforschung C · 1996 · 12 citations · Full text

, , +13

(+)-10 alpha-Hydroxy-4-muurolen-3-one, a new inhibitor of leukotriene biosynthesis from a Favolaschia species. Comparison with other sesquiterpenes.

Sylvia Zapf, Annette Wunder, Timm Anke et al. · PubMed · 1997 · 10 citations

, , +16

Rows per page

1–5 of 5